Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India

This publication has 13 references indexed in Scilit:

• Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
  American Journal of Hematology, 2021
• COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
  British Journal of Cancer, 2021
• Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
  The Lancet Haematology, 2021
• Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study
  HemaSphere, 2021
• Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
  Blood, 2020
• Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
  Blood Advances, 2020
• Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
  Journal of Hematology & Oncology, 2020
• COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
  The Lancet Oncology, 2020
• Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
  The Lancet Haematology, 2020
• Risk factors and outcome of COVID-19 in patients with hematological malignancies
  Experimental Hematology & Oncology, 2020